Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
JSH Co Ltd (150A.T)
Tokyo, JP
JSH Co Ltd operates in two primary sectors: local community revitalization, which includes providing employment support for individuals with disabilities and offering tourism-related services and products; and home-based medical care, encompassing psychiatric consultations delivered to clients' homes and comprehensive in-home nursing services.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.52% | +1.67% | -4.44% | -7.11% | -11.81% | -10.29% | -28.65% | -54.59% | -54.59% | -54.59% | -54.59% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-03 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%+19.5% ★ Q1'26: +29.1% (vs Q1'25)
-
EPS growth Conglomerates: +16.9%-185.0% Q1'26: +50.3% (vs Q1'25)
-
FCF margin FCF growth · Conglomerates: +35.9%-5.9% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Conglomerates: +9.0%-2.2% Q1'26: +10.0% (vs Q1'25)
-
ROIC Conglomerates: +4.7%-4.4% Q1'26: +13.5% (vs Q1'25)
-
Share dilution Conglomerates: +0.0%-0.9% ★ Q1'26: -1.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×9.60× Q1'26: 1.64× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|
| Revenue |
3.97B
est: 4.05B (-2.0%)
|
4.70B
4.70B – 4.70B
+16.0% YoY
|
5.35B
5.35B – 5.35B
+13.8% YoY
|
| EBITDA |
325.49M
est: 283.05M (+15.0%)
|
328.47M
328.47M – 328.47M
+16.0% YoY
|
373.90M
373.90M – 373.90M
+13.8% YoY
|
| EBIT |
176.28M
est: 142.38M (+23.8%)
|
165.23M
165.23M – 165.23M
+16.0% YoY
|
188.08M
188.08M – 188.08M
+13.8% YoY
|
| Net Income |
144.15M
est: 181.19M (-20.4%)
|
251.97M
251.97M – 251.97M
+39.1% YoY
|
352.19M
352.19M – 352.19M
+39.8% YoY
|
| SGA |
1.27B
est: 1.30B (-2.4%)
|
1.51B
1.51B – 1.51B
+16.0% YoY
|
1.72B
1.72B – 1.72B
+13.8% YoY
|
| EPS |
25.67
est: 32.00 (-19.8%)
|
44.50
44.50 – 44.50
+39.1% YoY
|
62.20
62.20 – 62.20
+39.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kazuki Noguchi | President & Chairman | — | male |
| Shinji Ichikawa | Head of Business Management Group & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 150A.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
